Avery, Billie Jean

Procedural entryThis page is a short order in Avery, Billie Jean. Read the opinion of the Court — 2012 Tex. Crim. App. LEXIS 360
Court of Criminal Appeals of Texas·Decided February 29, 2012·No. PD-0864-11·Published

Opinion

IN THE COURT OF CRIMINAL APPEALS OF TEXAS

NO. PD-0864-11

BILLIE JEAN AVERY, Appellant

v.

TH E STATE O F TEXAS

O N DISCRETIONARY REVIEW FRO M TH E TH IRTEENTH CO URT O F APPEALS BEE COUNTY

Womack, J., delivered the opinion of the unanimous Court.

The appellant was convicted of attempting to obtain a controlled substance “through use

of a fraudulent prescription form.”1 The Thirteenth Court of Appeals acquitted the appellant

because it found no evidence that she used a fraudulent prescription form.2 We shall affirm the

1 See T EX . H EALTH & S AFETY C O D E § 481.129(a)(5)(B).

2 Avery v. State, 341 S.W .3d 490 (Tex. App.–Corpus Christi 2011). Avery - 2

Court of Appeals’s judgment, though we disagree with some of the Court’s reasoning and

interpretation of the record.

I. Trial

The evidence showed that on January 15, 2009, the appellant complained to her doctor of

knee and back pain and received from him a prescription for forty 2.5 milligram Lortab pills.

Before she dropped off the prescription at the pharmacy, the appellant attempted to scribble out

the “2.5” and make it look like “7.5.” The on-duty pharmacist became suspicious and called the

office of the appellant’s doctor, where a nurse said that the prescription should have been for 2.5

milligram pills. The pharmacist then called store security, who contacted police.

After the State rested, the appellant moved for a directed verdict of acquittal. She argued

that, while there was evidence that she committed forgery, which might allow a conviction under

Healthy & Safety Code Section 481.129(a)(5)(A), there was no evidence that she used a

fraudulent prescription form as alleged in the indictment, which used the statutory manner and

means listed in Section 481.129(a)(5)(B):3

The testimony is that the prescription form is not fraudulent. It is the prescription form of the doctor. What the testimony has been is that the prescription, itself, that the doctor wrote on his form was altered. … There’s no evidence that [the appellant] committed this fraud by using a fraudulent prescription form ….

The State responded that by altering an otherwise legitimate prescription, the appellant

3 Health & Safety Code § 481.129 reads, in pertinent parts:

(a) A person commits an offense if the person knowingly: (5) possesses, obtains, or attempts to possess or obtain a controlled substance or an increased quantity of a controlled substance: (A) by misrepresentation, fraud, forgery, deception, or subterfuge; [or] (B) through use of a fraudulent prescription form; or (C) through use of a fraudulent oral or telephonically communicated prescription … . Avery - 3

had created a fraudulent prescription form. The trial court denied the appellant’s motion. The jury

found the appellant guilty and assessed her punishment of 25 years’ confinement and a $1,500

fine.

II. Direct Appeal

Before the Thirteenth Court of Appeals, the appellant argued that a “prescription form”

consisted of “only two elements: (1) the actual paper a practitioner uses to record a prescription;

and (2) that paper’s preprinted markings. In order for a prescription form to be fraudulent, one of

those elements must be directly affected by a fraudulent act.” Because her fraudulent act affected

only the prescription information handwritten by the doctor, the prescription form itself was not

fraudulent, and she was entitled to an acquittal.

The State countered by arguing that under Health & Safety Code Section 481.075 – which

outlines the “Official Prescription Program” that prescribers must follow in order to prescribe

Schedule II controlled substances4 – the elements of an “official prescription form” include the

controlled substance prescribed as well as the quantity of that controlled substance.5 Because the

prescriber’s written words were part of the “official prescription form,” according to the State,

when the appellant altered those written words she turned the entire document into a “fraudulent

prescription form.”

The Court of Appeals’s majority accepted neither party’s argument in full. It agreed with

the State that the prescription form was “essentially” an “official prescription form.”6 Instead of

4 See T EX . H EALTH & S AFETY C O D E § 481.075.

5 Id., at (e)(1).

6 Avery, 341 S.W .3d, at 497. Avery - 4

addressing whether the appellant’s actions fit the definition of using a “fraudulent prescription

form,” however, the Court of Appeals saw its job as determining whether the appellant’s actions

were “more” like the “misrepresentation, fraud, forgery, deception, or subterfuge” barred in

Section 481.129(a)(5)(A), or like the “use of a fraudulent prescription form,” barred in

Section 481.129(a)(5)(B).7 Because it determined that subsections (A) and (B) were mutually

exclusive – i.e., an action might fall under (A) or it might fall under (B), but it could not fall

under both – and because it determined that the appellant’s actions more closely resembled

“forgery” than “use of a fraudulent prescription form,” the Court of Appeals vacated the trial

court’s judgment and entered a verdict of acquittal.

III. Factual Matters

We granted the State’s petition for discretionary review to determine whether the Court of

Appeals correctly interpreted the phrase “fraudulent prescription form.” Before we can address

that matter, however, we need to address several factual matters in the Court of Appeals’s

opinion.

A. Lortab

The first sentence of the Court of Appeals’s opinion was:

Appellant, Billie Jean Avery, was charged by indictment with obtaining an increased quantity of a Schedule II controlled substance through the use of a fraudulent prescription form, a second-degree felony.8

We do not so read the record. The indictment alleged that the appellant attempted to use a

fraudulent prescription form “to obtain a controlled substance, namely, Lortab …” without

7 Id., at 498.

8 Id., at 491. Avery - 5

specifying which Schedule Lortab is on. The Court of Appeals cited to two cases stating that

hydrocodone, one of the ingredients in Lortab, is a Schedule II controlled substance.9 It also cited

to a website that described Lortab as a combination of hydrocodone and acetaminophen.10

A different page on that same website, however, states that certain mixtures that include

hydrocodone are Schedule III controlled substances.11 The Schedules published by the

Commissioner of Public Health confirm that hydrocodone is a Schedule II controlled substance,

but certain mixtures that include hydrocodone are Schedule III controlled substances.12

Although the record contains no information regarding the specific hydrocodone mixture

contained in the Lortab pills the appellant sought, it does contain the pharmacist’s testimony that

Lortab was a Schedule III controlled substance. There was no contradictory testimony or

arguments by the parties that she was mistaken.

We think that the record must be read to say that the prescription was for a Schedule III

controlled substance.

B. “Official Prescription Form”

That reading of the record means that the Court of Appeals was incorrect to have looked

to Health & Safety Code Section 481.075 as a source for determining the composite parts of a

9 Id., at 491 n.1 (citing Smith v. State, No.

Free access — add to your briefcase to read the full text and ask questions with AI

Avery, Billie Jean, (Tex. 2012).

Avery, Billie Jean (Avery, Billie Jean) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Jackson v. Virginia
443 U.S. 307 (Supreme Court, 1979)